Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells

American Journal of Transplantation

Volumn 16, Issue 1, 2016, Pages 58-71

  Dijke, I E ^a,b   Hoeppli, R E ^c   Ellis, T ^a,b   Pearcey, J ^a,b   Huang, Q ^c   McMurchy, A N ^c   Boer, K ^d   Peeters, A M A ^d   Aubert, G ^e   Larsen, I ^a,b   Ross, D B ^a,b   Rebeyka, I ^a,b   Campbell, A ^c   Baan, C C ^d   Levings, M K ^c   West, L J ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TELOMERE; THYMUS; ANIMAL; CELL CULTURE; CHILD; CYTOLOGY; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; SCID MOUSE; TELOMERE HOMEOSTASIS;

ADULT; ANIMALS; CELLS, CULTURED; CHILD; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TELOMERE HOMEOSTASIS; THYMUS GLAND;

EID: 84957082689     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13456     Document Type: Article

References (62)

1. Sakaguchi S., Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562.
2. Gorantla VS, Schneeberger S, Brandacher G, et al., T regulatory cells and transplantation tolerance. Transplant Rev (Orlando) 2010; 24: 147-159.
3. Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z., Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 2011; 10: 744-755.
4. Brusko TM, Putnam AL, Bluestone JA., Human regulatory T cells: Role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008; 223: 371-390.
5. McMurchy AN, Bushell A, Levings MK, Wood KJ., Moving to tolerance: Clinical application of T regulatory cells. Semin Immunol 2011; 23: 304-313.
6. Singer BD, King LS, D'Alessio FR., Regulatory T cells as immunotherapy. Front Immunol 2014; 5: 46.
7. Trenado A, Charlotte F, Fisson S, et al., Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003; 112: 1688-1696.
8. Joffre O, Santolaria T, Calise D, et al., Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008; 14: 88-92.
9. Kelchtermans H, Geboes L, Mitera T, Huskens D, Leclercq G, Matthys P., Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann Rheum Dis 2009; 68: 744-750.
10. Weigert O, von Spee C, Undeutsch R, Kloke L, Humrich JY, Riemekasten G., CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice. Arthritis Res Ther 2013; 15: R35.
11. Trzonkowski P, Bieniaszewska M, Juscinska J, et al., First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin Immunol 2009; 133: 22-26.
12. Brunstein CG, Miller JS, Cao Q, et al., Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 2011; 117: 1061-1070.
13. Di Ianni M, Falzetti F, Carotti A, et al., Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117: 3921-3928.
14. Marek-Trzonkowska N, Mysliwiec M, Dobyszuk A, et al., Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets-Results of one year follow-up. Clin Immunol 2014; 153: 23-30.
15. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S., Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389-399.
16. Taylor PA, Lees CJ, Blazar BR., The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493-3499.
17. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA., CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
18. Hoffmann P, Eder R, Boeld TJ, et al., Only the CD45RA+ subpopulation of CD4+CD25 high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108: 4260-4267.
19. Liu W, Putnam AL, Xu-Yu Z, et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701-1711.
20. Takahata Y, Nomura A, Takada H, et al., CD25+CD4+ T cells in human cord blood: An immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol 2004; 32: 622-629.
21. Riley JL, June CH, Blazar BR., Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 2009; 30: 656-665.
22. Hoffmann P, Boeld TJ, Eder R, et al., Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009; 39: 1088-1097.
23. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD., IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 2009; 183: 3170-3176.
24. Nie H, Zheng Y, Li R, et al., Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat Med 2013; 19: 322-328.
25. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I,. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112: 2340-2352.
26. Voo KS, Wang YH, Santori FR, et al., Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA 2009; 106: 4793-4798.
27. Dominguez-Villar M, Baecher-Allan CM, Hafler DA., Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med 2011; 17: 673-675.
28. McClymont SA, Putnam AL, Lee MR, et al., Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 2011; 186: 3918-3926.
29. Dittel BN., Depletion of specific cell populations by complement depletion. J Vis Exp 2010.
30. Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK., Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J Immunol 2013; 190: 2001-2008.
31. Cohen CJ, Crome SQ, MacDonald KG, Dai EL, Mager DL, Levings MK., Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J Immunol 2011; 187: 5615-5626.
32. Wieczorek G, Asemissen A, Model F, et al., Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009; 69: 599-608.
33. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM., Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 2006; 1: 2365-2376.
34. Cooke KR, Kobzik L, Martin TR, et al., An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88: 3230-3239.
35. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL., Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-3213.
36. Tang Q, Lee K., Regulatory T-cell therapy for transplantation: How many cells do we need? Curr Opin Organ Transplant 2012; 17: 349-354.
37. Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, Robbins PF., Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 2005; 175: 7046-7052.
38. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al., Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116: 2423-2433.
39. Weng NP., Telomeres and immune competency. Curr Opin Immunol 2012; 24: 470-475.
40. Khalil N,. TGF-beta: From latent to active. Microbes Infect 1999; 1: 1255-1263.
41. Hippen KL, Merkel SC, Schirm DK, et al., Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med 2011; 3: 83ra41.
42. Abraham S, Pahwa R, Ye C, et al., Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rgammac(null) mice by expression of human IL-2. PLoS ONE 2012; 7: e 51832.
43. Parmar S, Liu X, Tung SS, et al., Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease. Cytotherapy 2014; 16: 90-100.
44. Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E., Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 2002; 106: 190-199.
45. Klein L, Jovanovic K., Regulatory T cell lineage commitment in the thymus. Semin Immunol 2011; 23: 401-409.
46. Hsieh CS, Lee HM, Lio CW., Selection of regulatory T cells in the thymus. Nat Rev Immunol 2012; 12: 157-167.
47. Lio CW, Hsieh CS., Becoming self-aware: The thymic education of regulatory T cells. Curr Opin Immunol 2011; 23: 213-219.
48. Lio CW, Hsieh CS., A two-step process for thymic regulatory T cell development. Immunity 2008; 28: 100-111.
49. Toker A, Engelbert D, Garg G, et al., Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J Immunol 2013; 190: 3180-3188.
50. Aubert G, Lansdorp PM., Telomeres and aging. Physiol Rev 2008; 88: 557-579.
51. Aubert G, Baerlocher GM, Vulto I, Poon SS, Lansdorp PM., Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS Genet 2012; 8: e1002696.
52. Lin Y, Damjanovic A, Metter EJ, et al., Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions. Clin Sci (Lond) 2015; 128: 367-377.
53. Putnam AL, Brusko TM, Lee MR, et al., Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009; 58: 652-662.
54. Wing K, Larsson P, Sandstrom K, Lundin SB, Suri-Payer E, Rudin A., CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses. Immunology 2005; 115: 516-525.
55. Fujii Y, Okumura M, Inada K, Nakahara K, Matsuda H., CD45 isoform expression during T cell development in the thymus. Eur J Immunol 1992; 22: 1843-1850.
56. Borsellino G, Kleinewietfeld M, Di Mitri D, et al., Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225-1232.
57. Miyara M, Yoshioka Y, Kitoh A, et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
58. Collison LW, Pillai MR, Chaturvedi V, Vignali DA., Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 2009; 182: 6121-6128.
59. Steiner D, Brunicki N, Blazar BR, Bachar-Lustig E, Reisner Y., Tolerance induction by third-party "off-the-shelf" CD4+CD25+ Treg cells. Exp Hematol 2006; 34: 66-71.
60. Pierini A, Colonna L, Alvarez M, et al., Donor requirements for regulatory T cell suppression of murine graft-versus-host disease. J Immunol 2015; 195: 347-355.
61. Zhang H, Guo H, Lu L, et al., Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates. Am J Transplant 2015; 15: 1253-1266.
62. Carrel L, Willard HF,. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005; 434: 400-404.